>>TH1338

TH1338

Catalog No.GC62474

TH1338(화합물 3b), 경구 활성 캄토테신 유도체 및 암에 대한 강력한 화학요법제는 시험관 내에서 인간 종양 세포주에 대해 우수한 세포독성 효능을 나타냅니다. TH1338(화합물 3b)은 상당한 뇌 침투, 유리한 유출 펌프 특성 및 혈액학적 독성 프로파일을 가지고 있습니다.

Products are for research use only. Not for human use. We do not sell to patients.

TH1338 Chemical Structure

Cas No.: 1258494-60-8

Size 가격 재고 수량
10mM (in 1mL DMSO)
US$396.00
재고 있음
5 mg
US$360.00
재고 있음
10 mg
US$612.00
재고 있음
25 mg
US$1,215.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

TH1338 (compound 3b), an orally active camptothecin derivative and a potent chemotherapeutic agent for cancer, demonstrates excellent cytotoxic potency against human tumor cell lines in vitro. TH1338 (compound 3b) possesses significant brain penetration, favorable efflux pump properties, and hematological toxicity profile[1][2].

TH1338 (compound 3b) demonstrates significant brain penetration when dosed orally in mice[1].TH1338 (compound 3b) exhibits potent anti-tumor activity in H460 (NSCLC) human tumor xenograft model[1].

[1]. Jian-Xin Duan, et al. 14-Aminocamptothecins: their synthesis, preclinical activity, and potential use for cancer treatment. J Med Chem. 2011 Mar 24;54(6):1715-23.
[2]. Xia Cheng, et al. Preparation, Characterization, and In Vivo Study of 7-Ethyl-14-Aminocamptothecin-Loaded Poly(Ethylene Glycol)2000 -Poly(Lactic Acid)2000 Polymeric Micelles Against H460 Human Nonsmall Cell Lung Carcinoma. J Pharm Sci. 2015 Nov;104(11):3934-3942.

리뷰

Review for TH1338

Average Rating: 5 ★★★★★ (Based on Reviews and 39 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for TH1338

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.